Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug
Glenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated RRMM patients. The tri-specific antibody showed high response rates and a favorable safety profile in early trials. Complete results will be presented at (...)
Site référencé: The Economic Times
The Economic Times
DCM Shriram shares rally over 10% after Q4 profit jumps 52% YoY to Rs 179 crore
6/05/2025
ETMarkets PMS Talk : Karan Aggarwal on India’s 10-year wealth themes - Banks, infra & financial inclusion to lead
6/05/2025
Positive Breakout : These 9 stocks cross above their 200 DMAs
6/05/2025
Iware Supplychain shares to list today. GMP suggests muted listing ahead
6/05/2025
Q4 results today : Paytm, BSE among 53 companies to announce earnings on Tuesday
6/05/2025
Ather Energy to make its market debut today. Check GMP ahead of listing
6/05/2025
